Antigenicity of low molecular weight surfactant species
- PMID: 2705504
- PMCID: PMC1879782
Antigenicity of low molecular weight surfactant species
Abstract
The authors tested the antigenicity of human lung surfactant isolated from amniotic fluid. Mice and rabbits were immunized. Rabbit polyclonal antisera to these surfactant preparations were absorbed with normal human plasma proteins. Polyclonal antisera reacted with both high molecular weight (35 kd) surfactant apoprotein and to lower molecular weight species, both 18 kd and 9 kd. Mice were used to generate monoclonal antibodies to surfactant. Enzyme-linked immunosorbant assay was used to identify five monoclonal antibodies that reacted with surfactant. By Western blot analysis, all of these recognized a low molecular weight surfactant species (9 kd) that could be either SP-B or SP-C. One reacted with a 37 kd protein in the surfactant preparation, consistent with SP-A. One monoclonal antibody also recognized a higher molecular weight species (44 kd) of unknown origin. The ability of antisera and monoclonal antibodies to inhibit the functional activity of surfactant was assayed using a pulsating bubble surfactometer. Rabbit polyclonal antisera inhibited initial surface adsorption to equilibrium surface tension and increased the minimum surface tension after 1 and 5 minutes of initiation of pulsations. This inhibitory activity of the antisera was noted in divalent F(ab')2 fragments. Monovalent F(ab) fragments and control normal rabbit sera did not inhibit surfactant function in this assay. Of the anti-surfactant monoclonal antibodies that reacted with surfactant by ELISA and Western blot, three inhibited its capacity to lower surface tension on the pulsating bubble apparatus. The other two monoclonal antibodies showed no functional inhibitory activity. It is concluded that both the 35 kd SP-A and the 9 kd proteins of human surfactant are highly immunogenic and partially crossreactive. Resulting antibodies could alter the ability of surfactant to perform its physiologic function, ie, to lower surface tension.
Similar articles
-
Immunogenicity of surfactant. I. Human alveolar surfactant.Clin Exp Immunol. 1991 Jan;83(1):35-40. doi: 10.1111/j.1365-2249.1991.tb05584.x. Clin Exp Immunol. 1991. PMID: 1988229 Free PMC article.
-
An antibody with specificity for surfactant protein C precursors: identification of pro-SP-C in rat lung.Am J Respir Cell Mol Biol. 1992 Oct;7(4):368-78. doi: 10.1165/ajrcmb/7.4.368. Am J Respir Cell Mol Biol. 1992. PMID: 1389209
-
Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.J Clin Invest. 1988 Mar;81(3):826-33. doi: 10.1172/JCI113391. J Clin Invest. 1988. PMID: 3343343 Free PMC article.
-
The relationship between lamellar bodies and lysosomes in type II pneumocytes.Am J Respir Cell Mol Biol. 1991 Jun;4(6):504-13. doi: 10.1165/ajrcmb/4.6.504. Am J Respir Cell Mol Biol. 1991. PMID: 2054192
-
Production of polyclonal antisera.Curr Protoc Immunol. 2001 May;Chapter 2:2.4.1-2.4.9. doi: 10.1002/0471142735.im0204s13. Curr Protoc Immunol. 2001. PMID: 18432769 Review.
Cited by
-
Immunogenicity of surfactant. I. Human alveolar surfactant.Clin Exp Immunol. 1991 Jan;83(1):35-40. doi: 10.1111/j.1365-2249.1991.tb05584.x. Clin Exp Immunol. 1991. PMID: 1988229 Free PMC article.
-
Immunogenicity of surfactant. II. Porcine and bovine surfactants.Clin Exp Immunol. 1991 Jan;83(1):41-6. doi: 10.1111/j.1365-2249.1991.tb05585.x. Clin Exp Immunol. 1991. PMID: 1988231 Free PMC article.
-
A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group.Eur J Pediatr. 1992 May;151(5):372-6. doi: 10.1007/BF02113261. Eur J Pediatr. 1992. PMID: 1396894 Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources